Essink B, Chu L, Seger W, Barranco E, et al. The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials. Lancet Infect Dis 2023 Jan 19:S1473-3099(22)00764.
PMID: 36682364